Evidence map›Paper›PMID 33645289›Full record

ArticleEuropean journal of ophthalmology2022

A novel missense

Aino Maaria Jaakkola, Petri J Järventausta, Reetta-Stiina Järvinen, Pauliina Repo, Tero T Kivelä, Joni A Turunen

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Confirmation of association ofOphthalmic genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aino Maaria JaakkolaDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID https://orcid.org/0000-0002-1097-9596
Petri J JärventaustaDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Reetta-Stiina JärvinenDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pauliina RepoDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tero T KiveläDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Joni A TurunenDepartment of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe describe the phenotype of a variant lattice corneal dystrophy (LCD) potentially caused by a novel variant c.1772C>T p.(Ser591Phe) in exon 13 of the transforming growth factor beta-induced CASE REPORT: The proband, a 71-year-old woman referred because of bilateral LCD, first seen at the age of 65 years, with recent progressive symptoms, underwent a clinical ophthalmological examination, anterior segment optical coherence tomography and confocal microscopy. Additionally, three siblings and three children were examined. The identified

conclusionsWe classify the novel variant in

Indexed as

Corneal Dystrophies, HereditaryTransforming Growth Factor betaDNA Mutational AnalysisExtracellular Matrix ProteinsFinlandHumansMutationPedigreeExtracellular Matrix ProteinsTransforming Growth Factor betaamyloidCorneal dystrophylattice corneal dystrophypathogenic variantTGFBI

Identifiers

PMID33645289
PMCPMC9294436
OpenAlexW3134586568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.